Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 7, 2014
Effectiveness of plasma treatment on gastric cancer cellsKoji Torii, Suguru Yamada, Kae Nakamura, et al.
JMIR Mhealth and Uhealth|May 23, 2022
Adolescent Health Promotion Interventions Using Well-Care Visits and a Smartphone Cognitive Behavioral Therapy App: Randomized Controlled TrialShinichiro Nagamitsu, Ayako Kanie, Kazumi Sakashita, et al.
Annals of Gastroenterological Surgery|September 29, 2021
Surgical outcomes in gastroenterological surgery in Japan: Report of the National Clinical Database 2011-2019Shigeru Marubashi, Arata Takahashi, Yoshihiro Kakeji, et al.
The Oncologist|July 28, 2018
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)Goro Nakayama, Ayako Mitsuma, Yuki Sunagawa, et al.
Annals of Gastroenterological Surgery|May 8, 2023
Annual report on National Clinical Database 2020 for gastroenterological surgery in JapanYoshiki Kajiwara, Arata Takahashi, Hideki Ueno, et al.
Nagoya Journal of Medical Science|March 20, 2024
Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancerKoki Nakanishi, Chie Tanaka, Mitsuro Kanda, et al.
Antimicrobial Resistance and Infection Control|September 29, 2022
Use of broad-spectrum antimicrobials for more than 72 h and the detection of multidrug-resistant bacteria in Japanese intensive care units: a multicenter retrospective cohort studyHideki Yoshida, Takako Motohashi, Liesbet De Bus, et al.
Microbiology Spectrum|June 12, 2024
No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort studyJunki Ishii, Mitsuaki Nishikimi, Liesbet De Bus, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2020
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)Goro Nakayama, Nao Takano, Hiroya Taniguchi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2021
Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at BaselineShintaro Iwama, Tomoko Kobayashi, Yoshinori Yasuda, et al.
Pageof 31